Clinical trial
Patient Study to Evaluate the Safety and Emollient Performance of Doublebase Once in the Treatment of Psoriasis
NCT07817394 is registered in ClinicalTrials.gov with Dermal Laboratories Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Patient Study to Evaluate the Safety and Emollient Performance of Doublebase Once in the Treatment of Psoriasis
- Lead sponsor
- Dermal Laboratories Ltd
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- September 21, 2026
- Completion date
- October 31, 2026
- Enrollment
- 100 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.